UNSPSC 51181602: Liothyronine

This classification denotes a generic primary tumor tnm finding with the molecular formula C15H12I3NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06LU7C9H1V, chemically known as 3,5,3-triiodothyronine but generally known as liothyronine, which bears US NIH Compound Identifier 861. European Medicines Agency schedules Liothyronine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08527MIG.

UNSPSC 51181602 Liothyronine is a Commodity code covering the procurement of this synthetic thyroid hormone medication by state and local health and human services agencies, correctional systems, and public health departments. State and local governments purchase liothyronine primarily through group purchasing organizations, state pharmacy benefit managers, and direct contracts with pharmaceutical suppliers and wholesalers to stock correctional facilities, state hospitals, clinics, and emergency departments. The medication is typically acquired as part of broader pharmaceutical inventory management or through specialized purchasing agreements that bundle thyroid replacement therapies. Issuing bodies include state departments of health, corrections, and human services; county health authorities; and public hospital systems. Purchases reflect routine pharmaceutical stocking needs rather than episodic procurement and often occur through cooperative purchasing vehicles or standing agreements rather than competitive RFPs for individual line items.

The source provides no recent opportunities or geographic activity data for this Commodity code. Without posted RFP, RFQ, IFB, or ITB records naming specific issuing bodies, response dates, or jurisdictions, the current market visibility for liothyronine procurement under this code cannot be characterized. Procurement professionals pursuing this code should monitor state pharmacy and health department solicitation boards directly and track cooperative purchasing catalogs offered through organizations such as Premier, Vizient, and state group purchasing networks, where pharmaceutical commodities like liothyronine are frequently acquired off-contract.